Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJ. Alfred Witjes, María J. Ribal, Thierry Lebrét et al.|European Urology|2016Cited by 1.5k
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic ReviewErik Veskimäe, Éva Compérat, Estefanía Linares et al.|European Urology Oncology|2019Cited by 131
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maria Carmen Mir, Tobias Klatte et al.|European Urology Oncology|2020Cited by 34
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC RegistryMargaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Clinical Genitourinary Cancer|2022Cited by 21
Muscle-invasive and Metastatic Bladder CancerÉva Compérat, Erik Veskimäe, Maria De Santis et al.|Unknown|2016Cited by 15